Medical Bulletin 31/January/2023 Isra Zaman31 Jan 2023 12:00 PM GMTHere are the top medical news for the day:Anti-inflammatory effect of coffee with milk foundPolyphenols are a group of naturally occurring...
Understanding of graft-versus-host disease reframed in new study Isra Zaman31 Jan 2023 4:00 AM GMTAllogeneic stem cell transplantation involves infusion of stem cells from a healthy donor's blood or bone marrow to a recipient. While often...
Medical Bulletin 17/December/2022 Isra Zaman17 Dec 2022 8:45 AM GMTHere are the top medical news for the day:New, safer treatment for serious side effect of bone marrow transplant identifiedThe clinical trial in...
New, safer treatment for serious side effect of bone marrow transplant identified Isra Zaman17 Dec 2022 3:30 AM GMTThe clinical trial in adolescents and adults found that a drug that inhibits the immune system in patients who have graft-versus-host disease (GvHD)...
Janssen bags USFDA nod for IMBRUVICA for chronic graft-versus-host disease treatment Ruchika Sharma28 Aug 2022 7:15 AM GMTChronic graft-versus-host disease is a life-threatening complication that can occur after a stem cell or bone marrow transplant when newly...
Novartis Ruxolitinib Gets CDSCO Panel Okay for Acute and Chronic Graft Versus Host Disease Dr. Divya Colin22 July 2022 12:30 PM GMTNew Delhi: In response to the pharma major Novartis proposal for additional indication of Ruxolitinib Tablets 5/10/15/20 mg, the Subject Expert...
Novartis gets European Commission nod for Jakavi to treat acute, chronic graft-versus-host disease Ruchika Sharma8 May 2022 4:45 AM GMTGvHD occurs when donor cells see the recipient's healthy cells as foreign and attack them.
Venetoclax addition to standard treatments improves survival in myeloid blood cancers: Study Hina Zahid7 Dec 2020 3:00 AM GMTThe novel oral drug venetoclax can be safely added to standard therapies for some high-risk myeloid blood cancers and in early studies the combination...
